CIK 0002010788 · <br>Emerging growth company
EXOZYMES INC.
Sign in to watch- Ticker
- EXOZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 834550057
- Phone
- (626) - 415 - 1488
- Business address
- 750 ROYAL OAKS DR, MONROVIA, CA, 91016
- Former names
- Invizyne Technologies Inc
- 4 Open-market sale Chief Commercial Officer sold 3,729 shares at $5.21 ($19,427)
- 4/A Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 855 shares at an average $7.49 ($6,405)
- 4 Option exercise Chief Commercial Officer acquired 19,612 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 32,964 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 1,500 shares at an average $10.28 ($15,424)
- 4 Grant or award Chief Commercial Officer acquired 62,759 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Commercial Officer acquired 8,887 shares (grant or award)
- 4 Grant or award Vice President, Development acquired 3,999 shares (grant or award)
- 4 Grant or award Vice President- Finance acquired 5,999 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 5,332 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 1,040 shares at $10.22 ($10,629)
Page 1 of 2 · 40 filings